Real World Evidence Solutions Market to Reach $12.44 Billion by 2031

The global market for Real World Evidence (RWE) solutions is projected to reach $12.44 billion by 2031, an increase from an estimated $6.22 billion in 2026. This represents a compound annual growth rate (CAGR) of 14.9% over the forecast period.

Market growth is attributed to several factors, including the increasing need for efficient drug and medical device development and the rising costs within the healthcare sector. RWE solutions are increasingly being utilized for purposes such as clinical trial optimization, regulatory submissions, and post-market surveillance of pharmaceutical products.

The RWE solutions market encompasses a variety of tools and services designed for collecting, analyzing, and reporting real-world health data. These include electronic health records, medical device registries, and patient-reported outcome measures.

According to MarketsandMarkets, technological advancements and evolving regulatory landscapes that support the use of RWE data in healthcare decision-making are expected to drive further expansion of this market.